Clin2
NCT07640139Possibly a fitEnrolling by invitation

Study of Weight-Loss Medications' Health and Cost Effects

Obesity

Part of Hormones & metabolism clinical trials.

This research study looks at how obesity medications affect people's health outcomes and healthcare costs. Researchers will track employees and their family members covered by participating Indiana employers to understand whether these medications help improve conditions like diabetes and heart health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
125,000 people
Ages
18 years to 64 years
Study type
Observational

Who can take part

  • You live in Indiana and get health insurance through a participating employer
  • You are between 18 and 64 years old
  • You have a BMI (body mass index) of 30 or higher, OR a BMI of 25+ with a weight-related condition like high blood pressure or diabetes
  • You've had continuous health insurance coverage for at least 6 months before joining the study
  • You haven't had weight-loss surgery or been treated with certain diabetes or weight-loss medications before
  • You don't have conditions that would make obesity medications unsafe, such as a family history of thyroid cancer or certain eating disorders

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07598981Recruiting
Obesity Medication Safety and Effectiveness Registry

This registry tracks how well obesity medications work and their safety in real-world use. You'll share your health information and experiences with your obesity medication over time to help doctors understand what works best for different people.

Waltham, Massachusetts
NCT07503210Recruiting· Phase 3
Study of a new medicine to maintain weight loss

This study tests an investigational medicine to help people who have lost weight keep it off. It's for adults without diabetes who haven't used similar weight-loss drugs before.

Anniston, Alabama
NCT06174389Recruiting
Weight loss study: diet, appetite and body changes

This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.

Seattle, Washington
NCT06700538Recruiting· Phase 1/Phase 2
Study of an experimental drug for obesity with or without type 2 diabetes

This study tests an experimental medication called ARO-INHBE in adults with obesity, including those who also have type 2 diabetes. The goal is to see if it helps with weight loss and is safe.

Charlestown
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07793019Not yet recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.